Assessing the risk of sarcopenia in the elderly: The Mini Sarcopenia Risk Assessment (MSRA) questionnaire

Rossi, Andrea P.; Micciolo, Rocco; Rubele, Sofia; Fantin, Francesco; Caliari, Cesare; Zoico, Elena; Mazzali, Gloria; Ferrari, E; Volpato, Stefano; Zamboni, Mauro

doi:10.1007/s12603-017-0921-4

Cited by 73 publications

(89 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[10][11][12]14,29 Meanwhile, the SARC-F has been compared with other evaluation methods for determining sarcopenia. The SARC-F has been related to the MSRA 18,26 and a short portable sarcopenia measure, 29 which showed that the SARC-F has good criterion validity. In the present study, we used the MSRA for evaluating criterion validity.…”

Section: Discussionmentioning

confidence: 99%

“…Frailty was assessed using the Kihon Checklist (KCL) . We used the Mini Sarcopenia Risk Assessment (MSRA) questionnaire as an external reference for evaluating criterion‐related validity . The MSRA comprises seven items assessing the following: (i) age; (ii) hospitalization in the past year; (iii) activity level; (iv) meals; (v) milk consumption; (vi) protein consumption; and (vii) weight loss.…”

Section: Methodsmentioning

confidence: 99%

“…Item 7 was altered to “Have you lost 2 kg or more in the past 6 months?” There are two versions of the MSRA – the MSRA5, a short version comprising five items (Items 1–4 and Item 7); and the MSRA7, comprising all seven items. The MSRA5 and MSRA7 assign different numbers of points to items that are scored positively; hence, points were assigned following the system used in the original study …”

Section: Methodsmentioning

confidence: 99%

“…The MSRA5 and MSRA7 assign different numbers of points to items Validation study for Japanese version of SARC-F © 2019 Japan Geriatrics Society | 1173 that are scored positively; hence, points were assigned following the system used in the original study. 18…”

Section: Iadl Kcl and External Criterion For The Sarc-fmentioning

confidence: 99%

See 3 more Smart Citations

SARC‐F: A validation study with community‐dwelling older Japanese adults

Kera

Kawai

Hirano

et al. 2019

Geriatrics Gerontology Int

View full text Add to dashboard Cite

Aim The SARC‐F is a useful clinical index for sarcopenia screening; however, this measure has low sensitivity. Furthermore, this tool has never been validated on community‐dwelling older Japanese adults. The goal of the present study was to validate a Japanese version of the SARC‐F and confirm its suitability for Japanese samples. Methods Participants were 734 community‐dwelling older adults in the Itabashi Ward, Japan. Bioimpedance measures, walking speed, grip strength and instrumental activities of daily living (IADL) were measured. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People, the Asian Working Group for Sarcopenia criteria and Japanese‐adjusted Asian Working Group for Sarcopenia. SARC‐F receiver operating characteristic curves for each sarcopenia measure were used to evaluate diagnostic accuracy. Physical functioning, IADL and sarcopenia screening tools were compared with the SARC‐F. Results A total of nine men (3.1%) and 15 women (3.4%) were classified into a SARC‐F sarcopenia group. The sarcopenia group had lower physical functioning and Mini Sarcopenia Risk Assessment scores and higher frailty status than the control group. The Cronbach's alpha for the SARC‐F was 0.610, suggesting insufficient internal consistency. SARC‐F scores were related to physical functioning, IADL, and Mini Sarcopenia Risk Assessment scores. Receiver operating characteristic analyses of the SARC‐F based on each criterion showed low sensitivity, but high specificity. Conclusions The Japanese version of the SARC‐F appears to be a useful index for reflecting physical functioning and IADL. However, it is necessary to further determine whether this tool is useful for detecting sarcopenia among community‐dwelling older adults. Geriatr Gerontol Int 2019; 19: 1172–1178.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Iadl Kcl and External Criterion For The Sarc-fmentioning

confidence: 99%

See 2 more Smart Citations

SARC‐F: A validation study with community‐dwelling older Japanese adults

Kera

Kawai

Hirano

et al. 2019

Geriatrics Gerontology Int

View full text Add to dashboard Cite

show abstract

“…Questionnaires are proposed as an initial screening test to confirm clinical suspicions or avoid further investigation. The Mini Sarcopenia Risk Assessment (MSRA) questionnaire investigates anamnestic and nutritional characteristics related to the risk of sarcopenia (17); SARC-F is an easy-toapply questionnaire that asks daily-life questions, seeking answers based on the patient's perception of his or her limitations in strength, walking facility, capacity to rise from a chair, stair-climbing and any associated experiences with falls; a score ≥4 is predictive of sarcopenia and a poor outcome (18). Both questionnaires have demonstrated similar diagnostic accuracy, although SARC-F has offered better specificity.…”

Section: Clinical Questionnairesmentioning

confidence: 99%

MECHANISMS OF ENDOCRINE DISEASE: Sarcopenia in endocrine and non-endocrine disorders

Borba

Costa

Moreira

et al. 2019

European Journal of Endocrinology

View full text Add to dashboard Cite

Objective This paper reviews the main mechanisms, diagnostic criteria, treatment options and available data on sarcopenia in endocrine and non-endocrine disorders. The literature notes the presence of sarcopenia as a comorbid condition or a complication of another clinical situation and not a disease that only affects elderly patients. Method We performed a literature review, focusing on the following: mechanisms related to sarcopenia in elderly patients, and sarcopenia as it presents in the context of chronic and endocrine diseases; diagnostic tools and methods; aspects of sarcopenia and treatment options specific to chronic diseases and endocrine disorders respectively. Results Sarcopenia in chronic and endocrine disorders shares many mechanisms with sarcopenia affecting elderly patients, but certain diseases can have a predominant aspect that leads to sarcopenia. The prevalence of sarcopenia varies, depending on different diagnostic criteria, from around 12 to 60% in chronic illnesses and 15 to 90% in endocrine disorders. The interplay between sarcopenia, chronic diseases and elderly patients requires further study, to clarify the impact of each, in terms of prognosis and mortality. Conclusion Awareness of the presentation of sarcopenia in the context of other diseases and ages (and not just the elderly) is fundamental to ensure that preventive measures can be deployed.

show abstract

Recognizing Persons at Risk for Sarcopenia

Morley¹

2021

Sarcopenia

View full text Add to dashboard Cite

Assessing the risk of sarcopenia in the elderly: The Mini Sarcopenia Risk Assessment (MSRA) questionnaire

Cited by 73 publications

References 27 publications

SARC‐F: A validation study with community‐dwelling older Japanese adults

SARC‐F: A validation study with community‐dwelling older Japanese adults

MECHANISMS OF ENDOCRINE DISEASE: Sarcopenia in endocrine and non-endocrine disorders

Recognizing Persons at Risk for Sarcopenia

Contact Info

Product

Resources

About